Highlights
Flu Vaccine
The Advisory Committee on Immunization Practices (ACIP) recommends that several additional adult populations receive influenza (flu) vaccinations, including:
- All healthcare workers
- Patients with any condition that affects breathing
- Patients with any condition that produces respiratory secretions (for example, mucus from a runny nose or cough)
- People who live with those who are at high risk of flu complications
Text Continues Below

The CDC recommends that children under age nine receive two doses of the flu vaccine one month apart, because they do not develop a strong immune response from a single dose.
A 2004 review of multiple trials in Ontario, Canada (which provides flu shots to all healthy adults and children over 6 months of age) found universal immunization to be effective. Researchers also found that, when received within 36-48 hours of the first flu symptoms, the vaccine helps prevent household members and those in close contact to flu patients from getting sick.
Bacterial Meningitis
A new vaccine for bacterial meningitis (MCV4) was licensed in 2005 for people aged 11-55. ACIP recommendations now call for routine vaccination for all young adolescents (aged 11-12) as well as those previously defined as at increased risk.
Pertussis
- In April 2005, the US Food and Drug Administration (FDA) approved the first pertussis booster shot for kids aged 10 to 18. The booster shot, called Boostrix, is a lower dose of infant petussis vaccine. (The infant pertussis vaccine can start to wear off after about 5 years.)
- The FDA also approved a booster vaccine called Adacel for protection against tetanus, diphtheria and pertussis from adolescence through adulthood.